| Net Cash Provided by (Used in) Operating Activities |
$131,700,000 |
USD |
-48% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$47,800,000 |
USD |
-121% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$131,900,000 |
USD |
63% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
145,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
100 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$48,000,000 |
USD |
62% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$140,000,000 |
USD |
24% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$5,900,000 |
USD |
-59% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
310,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
450,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$187,600,000 |
USD |
5% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
310,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
100 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |